As Cynosure INC (CYNO) Stock Value Were Volatile, Holder Broadwood Capital INC Lifted Its Holding

July 17, 2017 - By Marry Poplack

Investors sentiment decreased to 1.14 in 2016 Q4. Its down 0.49, from 1.63 in 2016Q3. It is negative, as 37 investors sold CYNO shares while 53 reduced holdings. 36 funds opened positions while 67 raised stakes. 24.00 million shares or 5.74% more from 22.70 million shares in 2016Q3 were reported. Northwestern Mutual Wealth Mgmt accumulated 111 shares or 0% of the stock. Ubs Asset Americas, Illinois-based fund reported 4,409 shares. Principal Grp invested in 629,313 shares or 0.04% of the stock. 50,000 are owned by Grantham Mayo Van Otterloo And Com Lc. Deutsche Comml Bank Ag has invested 0% in Cynosure, Inc. (NASDAQ:CYNO). Bank Of Nova Scotia accumulated 7,610 shares or 0% of the stock. Loomis Sayles And Limited Partnership has 629,062 shares. 591,376 were accumulated by Wellington Mngmt Group Limited Liability Partnership. Comml Bank Of Montreal Can holds 0% or 48,711 shares. Sg Cap Mngmt holds 1.97% or 259,846 shares. 15,172 were reported by Gsa Capital Prns Llp. Federated Investors Incorporated Pa stated it has 0% in Cynosure, Inc. (NASDAQ:CYNO). Spark Invest Ltd Limited Liability Company has 0.1% invested in Cynosure, Inc. (NASDAQ:CYNO). Mcf Advsr Ltd Liability Company invested in 0.01% or 1,150 shares. Olstein LP owns 35,525 shares.

Neal C. Bradsher increased its stake in Cynosure Inc (CYNO) by 46% based on its latest 2016Q4 regulatory filing with the SEC. Broadwood Capital Inc bought 421,852 shares as the company’s stock 0.00% . The hedge fund run by Neal C. Bradsher held 1.34M shares of the health care company at the end of 2016Q4, valued at $61.05 million, up from 916,975 at the end of the previous reported quarter. Broadwood Capital Inc who had been investing in Cynosure Inc for a number of months, seems to be bullish on the $ market cap company. It is 0.00% or $0 reaching $0 per share. It is down 0.00% since July 17, 2016 and is . It has underperformed by 16.70% the S&P500.

More notable recent Cynosure, Inc. (NASDAQ:CYNO) news were published by: Fool.com which released: “Why Cynosure, Inc. Is Rising Today” on January 23, 2017, also Schaeffersresearch.com with their article: “Stocks On the Move: Cynosure, Inc., Kate Spade & Co, and NQ Mobile Inc” published on January 23, 2017, Law360.com published: “Cynosure Investors Sue To Block $1.4B Hologic Merger” on February 25, 2017. More interesting news about Cynosure, Inc. (NASDAQ:CYNO) were released by: Seekingalpha.com and their article: “Cynosure’s (CYNO) CEO Michael Davin on Q3 2016 Results – Earnings Call Transcript” published on October 25, 2016 as well as Prnewswire.com‘s news article titled: “Cynosure Recognized as One of FORTUNE’s 100 Fastest-Growing Companies” with publication date: September 30, 2016.

Cynosure, Inc. (NASDAQ:CYNO) Ratings Coverage

Among 3 analysts covering Cynosure Inc (NASDAQ:CYNO), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Cynosure Inc had 7 analyst reports since August 13, 2015 according to SRatingsIntel. Stifel Nicolaus upgraded the stock to “Buy” rating in Monday, September 14 report. The company was downgraded on Tuesday, February 14 by Maxim Group. The firm has “Sell” rating by Zacks given on Tuesday, August 18. Aegis Capital initiated Cynosure, Inc. (NASDAQ:CYNO) on Thursday, November 3 with “Buy” rating. The company was maintained on Tuesday, January 5 by Stifel Nicolaus. The company was initiated on Thursday, August 13 by Stifel Nicolaus. Maxim Group maintained the stock with “Buy” rating in Tuesday, December 22 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.